Drug Profile
Interferon alpha-2a biosimilar - Biopartners GmbH
Alternative Names: AlpheonLatest Information Update: 30 Oct 2021
Price :
$50
*
At a glance
- Originator Biopartners GmbH
- Class Antineoplastics; Antivirals; Interferons
- Mechanism of Action Immunostimulants
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
- New Molecular Entity No
Highest Development Phases
- Discontinued Hepatitis C